Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-11-05

Clinical Trial Update: Prevention of Dysrhythmias on the Cardiac Intensive Care Unit - Does Maintenance of High-normal Serum Potassium Levels Matter [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating whether maintaining high-normal serum potassium levels reduces dysrhythmias in patients in the cardiac intensive care unit.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Barts & The London NHS Trust | Conditions: Arrhythmias, Cardiac | Phase 3 | Status: COMPLETED